Jennifer Sengenès

Head of Strategy & Development at PEP-Therapy

Prior to joining PEP-Therapy in 2014, Jennifer worked as a Consultant within the innovation financing division of a consulting firm, and then served as a Project Manager in a nanotech start-up. She has 12 years of experience in project management, innovation strategy and financing, and start-up development.

Jennifer holds an engineering degree in chemistry, a Ph.D. in molecular biology combined with an MBA.

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


PEP-Therapy

PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.


Industries

Headquarters

Paris, France

Employees

1-10

Links